相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Gut immune cell trafficking: inter-organ communication and immune-mediated inflammation
Sebastian Zundler et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2023)
Residual homing of α4β7-expressing β1+PI16+ regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumab
Emily Becker et al.
GUT (2022)
Etrolizumab-s Does Not Induce Residual Trafficking of Regulatory T Cells
Anna Schweda et al.
INFLAMMATORY BOWEL DISEASES (2022)
Regulation and Role of αE Integrin and Gut Homing Integrins in Migration and Retention of Intestinal Lymphocytes during Inflammatory Bowel Disease
Mary E. Keir et al.
JOURNAL OF IMMUNOLOGY (2021)
Human Intestinal Macrophages Are Involved in the Pathology of Both Ulcerative Colitis and Crohn Disease
Suranga Dharmasiri et al.
INFLAMMATORY BOWEL DISEASES (2021)
Targeting Immune Cell Trafficking - Insights From Research Models and Implications for Future IBD Therapy
Maximilian Wiendl et al.
FRONTIERS IN IMMUNOLOGY (2021)
The kinetics of E-selectin- and P-selectin-induced intermediate activation of integrin alpha(L)beta(2) on neutrophils
Fangyuan Zhou et al.
JOURNAL OF CELL SCIENCE (2021)
Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine Hubs
Georg Schett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Non-classical monocyte homing to the gut via α4β7 integrin mediates macrophage-dependent intestinal wound healing
Lena Schleier et al.
GUT (2020)
The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti-integrin therapies
Iris Dotan et al.
MEDICINAL RESEARCH REVIEWS (2020)
Cell Trafficking Interference in Inflammatory Bowel Disease: Therapeutic Interventions Based on Basic Pathogenesis Concepts
Tamara Perez-Jeldres et al.
INFLAMMATORY BOWEL DISEASES (2019)
Rational and clinical development of the anti-MAdCAM monoclonal antibody for the treatment of IBD
Marjolijn Duijvestein et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2019)
Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease
Charlotte Lichnog et al.
FRONTIERS IN PHARMACOLOGY (2019)
Immune cell trafficking and retention in inflammatory bowel disease: mechanistic insights and therapeutic advances
Sebastian Zundler et al.
GUT (2019)
Targeting immune cell circuits and trafficking in inflammatory bowel disease
Markus F. Neurath
NATURE IMMUNOLOGY (2019)
Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease
Sebastian Zeissig et al.
GUT (2019)
Similar Inhibition of Dynamic Adhesion of Lymphocytes From IBD Patients to MAdCAM-1 by Vedolizumab and Etrolizumab-s
Marie-Theres Binder et al.
INFLAMMATORY BOWEL DISEASES (2018)
Targeting Endothelial Ligands: ICAM-1/alicaforsen, MAdCAM-1
Walter Reinisch et al.
JOURNAL OF CROHNS & COLITIS (2018)
Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individuals
Mathieu Uzzan et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn's disease: report of the OPERA study
William J. Sandborn et al.
GUT (2018)
Blockade of αEβ7 integrin suppresses accumulation of CD8+ and Th9 lymphocytes from patients with IBD in the inflamed gut in vivo
Sebastian Zundler et al.
GUT (2017)
Three-Dimensional Cross-Sectional Light-Sheet Microscopy Imaging of the Inflamed Mouse Gut
Sebastian Zundler et al.
GASTROENTEROLOGY (2017)
The α4β1 Homing Pathway Is Essential for Ileal Homing of Crohn's Disease Effector T Cells In Vivo
Sebastian Zundler et al.
INFLAMMATORY BOWEL DISEASES (2017)
Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial
Severine Vermeire et al.
LANCET (2017)
Chemically induced mouse models of acute and chronic intestinal inflammation
Stefan Wirtz et al.
NATURE PROTOCOLS (2017)
Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo
Anika Fischer et al.
GUT (2016)
Leukocyte Trafficking to the Small Intestine and Colon
Aida Habtezion et al.
GASTROENTEROLOGY (2016)
Distinct Chemokine Signaling Regulates lntegrin Ligand Specificity to Dictate Tissue-Specific Lymphocyte Homing
Hao Sun et al.
DEVELOPMENTAL CELL (2014)
Blockade of lymphocyte trafficking in inflammatory bowel diseases therapy: importance of specificity of endothelial target
Mariangela Allocca et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2014)
Domain 1 of Mucosal Addressin Cell Adhesion Molecule Has an I1-set Fold and a Flexible Integrin-binding Loop
Yamei Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
In vitro assessment of the effects of vedolizumab binding on peripheral blood lymphocytes
Timothy Wyant et al.
MABS (2013)
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Brian G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The role of neutrophils during intestinal inflammation
B. M. Fournier et al.
MUCOSAL IMMUNOLOGY (2012)
E-selectin engages PSGL-1 and CD44 through a common signaling pathway to induce integrin αLβ2-mediated slow leukocyte rolling
Tadayuki Yago et al.
BLOOD (2010)
The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti-alpha(4)beta(7) Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases
Dulce Soler et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
PECAM-1 (CD 31) mediates transendothelial leukocyte migration in experimental colitis
Emile Rijcken et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44
Andres Hidalgo et al.
IMMUNITY (2007)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Mechanisms of MAdCAM-1 gene expression in human intestinal microvascular endothelial cells
H Ogawa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
Mucosal vaccination increases endothelial expression of mucosal addressin cell adhesion molecule 1 in the human gastrointestinal tract
C Lindholm et al.
INFECTION AND IMMUNITY (2004)
Retinoic acid imprints gut-homing specificity on T cells
M Iwata et al.
IMMUNITY (2004)
Differential expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in ulcerative colitis and Crohn's disease
S Arihiro et al.
PATHOLOGY INTERNATIONAL (2002)
分享论文
